My Companies
Notification
Account
Log Out
Login
Acquired Wellness Portfolio of Group Pharmaceuticals (stake not specified) for Rs 23.7cr upfront plus up to Rs 23cr linked to FY28 sales (cap Rs 46.7cr). Target is wellness Rx portfolio (hematinic, respiratory) with Rs 24.6cr FY26 revenue, closed 1 Oct 2026. Context: pending tuck-in closed ahead of November deadline.
Jagsonpal Pharmaceuticals Acquires Group Pharma Wellness Portfolio For Rs46.7 Crore
Jagsonpal Pharmaceuticals Acquires 85% Stake In Aequitas For ₹20.8 Crore